Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma
10.1210/jc.2011-1245
Saved in:
Main Authors: | Wu, Z.-S., Yang, K., Wan, Y., Qian, P.-X., Perry, J.K., Chiesa, J., Mertani, H.C., Zhu, T., Lobie, P.E. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/108586 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C
by: Bougen, N.M., et al.
Published: (2014) -
Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells
by: Bougen, N.M., et al.
Published: (2014) -
Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone
by: Kaulsay, K.K., et al.
Published: (2014) -
Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone
by: Mukhina, S., et al.
Published: (2016) -
Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival
by: Mertani, H.C., et al.
Published: (2014)